ACAD
35.91
-0.72
-1.97%
AEMD
7.6
+0.01
+0.13%
APRI
1.78
+0.08
+4.71%
ARNA
2.56
-0.15
-5.54%
ATEC
0.58
0.00
+0.87%
CNAT
3.73
-0.2
-5.09%
CRXM
0.35
-0.02
-5.41%
CYTX
0.38
+0.02
+4.94%
DXCM
87.82
-6.32
-6.71%
GNMK
9.66
-0.68
-6.58%
HALO
16.62
-0.84
-4.81%
ILMN
193.13
-4.48
-2.27%
INNV
0.13
-0.018
-12.2297%
INO
7.1
-0.39
-5.21%
ISCO
3.8
-0.1
-2.56%
ISIS
48.75
-1.43
-2.85%
LGND
88.48
-3.46
-3.76%
LPTN
0.25
+0.02
+8.70%
MBVX
1.8
+0.05
+2.86%
MEIP
1.8
-0.02
-1.10%
MNOV
3.05
+0.1
+3.39%
MRTX
26.57
+0.75
+2.90%
MSTX
0.48
-0.01
-1.03%
NBIX
47.05
+0.67
+1.44%
NUVA
52.01
-0.71
-1.35%
ONCS
5.77
+0.39
+7.25%
ONVO
2.45
-0.28
-10.26%
OREX
2.68
-0.09
-3.25%
OTIC
21.45
-1.22
-5.38%
QDEL
20.28
-0.31
-1.51%
RCPT
231.96
0.00
0.00%
RGLS
8.26
-0.07
-0.84%
RMD
50.75
-1.19
-2.29%
SCIE
0.014
0.00
0.00%
SPHS
0.85
-0.05
-5.56%
SRNE
12.46
-0.22
-1.74%
TROV
5.72
-0.23
-3.87%
VICL
0.61
+0.02
+3.35%
VOLC
18
0.00
0.00%
ZGNX
18.48
-0.74
-3.85%
ACAD
35.91
-0.72
-1.97%
AEMD
7.6
+0.01
+0.13%
APRI
1.78
+0.08
+4.71%
ARNA
2.56
-0.15
-5.54%
ATEC
0.58
0.00
+0.87%
CNAT
3.73
-0.2
-5.09%
CRXM
0.35
-0.02
-5.41%
CYTX
0.38
+0.02
+4.94%
DXCM
87.82
-6.32
-6.71%
GNMK
9.66
-0.68
-6.58%
HALO
16.62
-0.84
-4.81%
ILMN
193.13
-4.48
-2.27%
INNV
0.13
-0.018
-12.2297%
INO
7.1
-0.39
-5.21%
ISCO
3.8
-0.1
-2.56%
ISIS
48.75
-1.43
-2.85%
LGND
88.48
-3.46
-3.76%
LPTN
0.25
+0.02
+8.70%
MBVX
1.8
+0.05
+2.86%
MEIP
1.8
-0.02
-1.10%
MNOV
3.05
+0.1
+3.39%
MRTX
26.57
+0.75
+2.90%
MSTX
0.48
-0.01
-1.03%
NBIX
47.05
+0.67
+1.44%
NUVA
52.01
-0.71
-1.35%
ONCS
5.77
+0.39
+7.25%
ONVO
2.45
-0.28
-10.26%
OREX
2.68
-0.09
-3.25%
OTIC
21.45
-1.22
-5.38%
QDEL
20.28
-0.31
-1.51%
RCPT
231.96
0.00
0.00%
RGLS
8.26
-0.07
-0.84%
RMD
50.75
-1.19
-2.29%
SCIE
0.014
0.00
0.00%
SPHS
0.85
-0.05
-5.56%
SRNE
12.46
-0.22
-1.74%
TROV
5.72
-0.23
-3.87%
VICL
0.61
+0.02
+3.35%
VOLC
18
0.00
0.00%
ZGNX
18.48
-0.74
-3.85%
Home » Archive by Author

Articles by Mary Canady

The Biotech/Pharma Project Manager’s Toolkit Begins January 23rd: Frequently Asked Questions (FAQ’s)

January 20, 2015 – 11:31 am
iStock_chalkboard FAQ2

We’ve been working closely with UCSD Extension to provide customized life science training that SDBN members are seeking, see our recent press release and event. Our first offering begins January 23rd, the Biotech/Pharma Project Manager’s …

UCSD Extension and San Diego Biotechnology Network Partner To Engage, Educate, and… — SAN DIEGO, Jan. 9, 2015 /PRNewswire-iReach/ –

January 9, 2015 – 9:16 am

UCSD Extension and San Diego Biotechnology Network Partner To Engage, Educate, and… — SAN DIEGO, Jan. 9, 2015 /PRNewswire-iReach/ –.

SDBN February 2nd 2015 Speed Networking Event: Make Every Second Count!

January 8, 2015 – 12:17 pm
lab timer 2

The San Diego Biotechnology Network hosts a speed networking event twice a year because it’s a great way for local life scientists and professionals to make connections, which is what we’re all about. Some would …

Research Associate job – Koliber Biosciences – Carlsbad, CA | Indeed.com

December 18, 2014 – 11:42 am

Job Description
Koliber Biosciences Inc. is synthetic biology start-up developing data science driven solutions for efficient microorganism engineering. We are currently seeking a Research Associate to join our strain engineering team. The Research Associate will provide …
The post Research Associate job – Koliber Biosciences – Carlsbad, CA | Indeed.com appeared first on San Diego Biotechnology Network.
The post Research Associate job – Koliber Biosciences – Carlsbad, CA | Indeed.com appeared first on San Diego Biotechnology Network.

First SDBN/UCSD Extension Offering To Begin January 2015: Biotech/Pharma Project Manager’s Toolkit

December 11, 2014 – 5:30 pm
15977741865_8a2162af85_m

The San Diego Biotechnology Network was formed in order to serve local life scientists, professionals and organizations and to help the region to not only grow, but thrive. Towards this end, we are working with …

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

BIO 2014: Innovations in 3-D Tissue for Disease and Drug Discovery | Xconomy

October 30, 2014 – 1:17 pm

BIO 2014: Innovations in 3-D Tissue for Disease and Drug Discovery | Xconomy.

SDBN November 17th 2014 Global Biotechnology Project Management Workshop and Networking Event

October 24, 2014 – 10:09 am
GlobalBiotechProjectManagement

The San Diego Biotechnology Network (SDBN) is teaming up with UCSD Extension to provide customized training and workshops to meet the local industry’s needs. In a July 2014 survey, 120 respondents indicated that biotech project …

SDBN November 17th 2014 Global Biotechnology Project Management Workshop and Networking Event

October 24, 2014 – 10:09 am

The San Diego Biotechnology Network (SDBN) is teaming up with UCSD Extension to provide customized training and workshops to meet the local industry’s needs. In a July 2014 survey, 120 respondents indicated that biotech project …

Upcoming World Antibody-Drug Conjugate (ADC) Meeting and Awards in San Diego… — SAN DIEGO, Calif., Oct. 21, 2014 /PRNewswire-iReach/ –

October 21, 2014 – 2:34 pm

Antibody-drug conjugates (ADCs) are one of the most exciting new classes of cancer therapeutics because they combine the potency of small molecules with the specificity of antibodies. California’s culture of innovation, as well as access to world class drug discovery and development expertise, has accelerated progress in ADC therapeutics, a market that was $396 million in 2013 and growing at a rate of 48% per year.